• Corcept Therapeutics reported President, Corcept Endocrinology Sean Maduck exercised options to buy 75,000 shares at $8.27 on May 27.
• Maduck sold 75,000 shares the same day at weighted-average prices of $65.37 and $66.16.
• He ended the day with 8,977 shares of common stock held directly.
• He also reported 166,986 stock options held directly following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-248967), on May 29, 2026, and is solely responsible for the information contained therein.